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The importance of estrogens in controlling brain and behavioral sexual diﬀerentiation in female rodents is an unresolved issue in the
ﬁeld of behavioral neuroendocrinology. Whereas, the current dogma states that the female brain develops independently of estradiol,
many studies have hinted at possible roles of estrogen in female sexual diﬀerentiation. Accordingly, it has been proposed that a-fetopro-
tein, a fetal plasma protein that binds estrogens with high aﬃnity, has more than a neuroprotective role and speciﬁcally delivers estrogens
to target brain cells to ensure female diﬀerentiation. Here, we review new results obtained in aromatase and a-fetoprotein knockout mice
showing that estrogens can have both feminizing and defeminizing eﬀects on the developing neural mechanisms that control sexual
behavior. We propose that the defeminizing action of estradiol normally occurs prenatally in males and is avoided in fetal females
because of the protective actions of a-fetoprotein, whereas the feminizing action of estradiol normally occurs postnatally in genetic
females.
 2007 Elsevier Inc. All rights reserved.
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The classic view of sexual diﬀerentiation in mammalian
species holds that sex diﬀerences in the brain develop under
the inﬂuence of testosterone and/or estradiol derived from
neural aromatization of testosterone: the brain develops as
male in the presence of these steroid hormones, and as
female in their absence. In agreement with this view, it
has been proposed by McEwen et al. [64] that the female
rodent brain needs to be protected from estrogens pro-
duced by the placenta or male siblings, and that a-fetopro-
tein (AFP)—an important fetal plasma protein present in
many developing vertebrate species and produced tran-
siently in great quantities by the hepatocytes of the fetal
liver [3,94]—is the most likely candidate to achieve this
protection because of its estrogen-binding capacity. How-
ever, the idea that the female brain develops in the absence0091-3022/$ - see front matter  2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.yfrne.2007.06.001
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E-mail address: jbakker@ulg.ac.be (J. Bakker).of estrogens as well as the role of AFP in protecting the
brain against the diﬀerentiating action of estrogens have
been challenged. First, there is evidence that the normal
development of the female brain might actually require
the presence of estrogens (e.g. [29,35]). Second, the pres-
ence of AFP within neurons in the absence of any evidence
for local AFP synthesis suggests that AFP is transported
from the periphery into the brain. It was therefore pro-
posed by Toran-Allerand [99] that AFP acts as a carrier,
which actively transports estrogens into target brain cells
and, by doing so, has an active role in the development
of the female brain. Thus, two clearly opposing views exist
on the function of AFP in the sexual diﬀerentiation of the
rodent brain, as well as on the role of estrogens in the
development of the female brain. In this review, we re-
examine the role of perinatal estrogens and consequently
the role of AFP in the development of the female brain
by discussing results obtained in two diﬀerent knockout
mouse models, i.e. the aromatase knockout (ArKO) mouse
[44] and the AFP-KO mouse [34]. Behavioral evidence
from these mouse models suggests that estrogens can have
Fig. 1. Sexual diﬀerentiation of the brain. In male rodents, testosterone
(T) secreted by the testes enters the brain where it is aromatized to
estradiol (E), which subsequently binds to the estradiol receptor to
promote gene expression that masculinize and defeminize the neural
mechanisms controlling sexual behavior.
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brain mechanisms that control sexual behavior. We there-
fore suggest here that the defeminizing action of estradiol
normally occurs prenatally in males and is avoided in fetal
females because of the protective actions of AFP. Further-
more, the feminizing action of estradiol normally occurs in
genetic females between birth and the age of puberty, when
the ovaries start to produce estrogens and AFP no longer
plays a signiﬁcant role.
2. Classical theory of brain and behavioral sexual
diﬀerentiation
In male mammals, the presence of the Sry gene on the
Y-chromosome causes the undiﬀerentiated gonads to
develop into testes instead of ovaries [50]. Testosterone
secreted by the testicular Leydig cells promotes the devel-
opment of the Wolﬃan ducts into the internal male genital
structures whereas anti-Mu¨llerian hormone secreted by tes-
ticular Sertoli cells causes regression of the female-typical
Mu¨llerian ducts. The penis and scrotum develop under
the inﬂuence of dihydrotestosterone which is formed from
testosterone by the enzyme, type II 5a-reductase. In normal
female diﬀerentiation, the Mu¨llerian ducts develop without
any apparent hormonal input into the uterus, the fallopian
tubes, and the distal portion of the vagina. The Wolﬃan
ducts regress and disappear in the absence of any andro-
genic stimulation. Phoenix and co-workers [75] provided
the ﬁrst evidence that the capacity to display sex-speciﬁc
behaviors in adulthood (and by inference, the sexual diﬀer-
entiation of the brain) follows the same pattern as that of
the genitals. Thus female guinea pigs treated with testoster-
one propionate in utero showed elevated levels of male-typ-
ical mounting behavior together with reduced levels of
female-typical lordosis behavior in adulthood [75]. Sup-
portive evidence for a role of perinatal testosterone in the
development of the male brain came from subsequent stud-
ies by Feder and Whalen [31], and Grady et al. [40], and
many others (reviewed in [10]) showing that removal of tes-
tosterone by neonatal castration reduced males’ later
capacity to show male sexual behaviors while enhancing
their ability to show female sexual behaviors. Additional
evidence suggested that testosterone secreted by the testes
acts perinatally, either directly via androgen receptors or
after being aromatized into estradiol and stimulating estra-
diol receptors ([58,68]) to masculinize (enhance male-typi-
cal sexual responses) and/or defeminize (suppress female-
typical responses) the neural substrate that controls sexual
behavior (Fig. 1). The results of these early studies also
implied that the neural mechanisms which control later
female-typical sexual behavior normally develop perina-
tally in females ‘‘by default’’, i.e. without the need for
any sex steroid stimulation. Consistent with this view is
the observation that the female ovaries are quiescent dur-
ing perinatal development, i.e. the rodent ovary does not
secrete signiﬁcant amounts of estradiol before postnatal
day 7 [53]. Accordingly, the fetal rodent ovary does notseem to express at least 3 of the enzymes (P450scc,
P450c17, and p450arom) that are necessary for estrogen
production whereas these enzymes are present in the fetal
rodent testis [41]. Finally, any estrogens secreted by the
mother during gestation are thought to be not available
to the fetal (male or female) rodent brain because they
are bound with high aﬃnity and capacity to a-fetoprotein
(AFP), a plasma glycoprotein produced in high quantities
by the fetal liver [3,64,94].3. Role of estradiol in female-typical brain and behavioral
sexual diﬀerentiation
Whereas, the concept of the male sexual diﬀerentiation
of the brain depending on the presence of testosterone
and/or estradiol has been based on the results of a large
number of studies (reviewed in [10,18,27,38,39,78]), the
concept of the female sexual diﬀerentiation of the brain
proceeding in the absence of these hormones has been pri-
marily based on assumptions. For example, the ﬁnding that
neonatally castrated male rats show lordosis behavior
when primed with ovarian hormones in adulthood cer-
tainly suggests that gonadal hormones may not be neces-
sary to develop the potential to show lordosis behavior in
adulthood; however, it does not prove that it is the case.
In fact, several studies have suggested that ovarian secre-
tions are necessary for a normal development of the female
brain, thereby challenging the concept of a default develop-
mental program for the female brain. However, it has been
proven diﬃcult to provide solid experimental evidence of a
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brain, mainly because of technical diﬃculties in manipulat-
ing estrogen levels (or neural actions) during early develop-
ment in females. Here, we will give a short overview of
some of these studies.
3.1. The role of the ovary in female sexual diﬀerentiation
In a ﬁrst approach to investigate the role of ovarian
hormones in female sexual diﬀerentiation, ovariectomy
was used as method to clear the developing female of cir-
culating estrogens. Thus, early studies by Jost [45] and
Pfeiﬀer [74] showed that fetal or neonatal gonadectomy
did not interfere with the female diﬀerentiation of the
genitals thereby setting the basis for the concept of a
default developmental program in the female. Estrogen
levels are shown to be very high during fetal develop-
ment [104] as well as during early postnatal life [65] in
females. It was thus assumed that ovariectomy would
render the developing female free from circulating estro-
gens. However, the ovaries are probably not the primary
source of these estrogens since they do not secrete any
detectable levels of estrogens before day 7 after birth
[53]. Thus any estrogens circulating in the fetal and new-
born female rodent must be derived from extra-ovarian
sources, such as the adrenal glands [36], the mother
[116] or male siblings that are adjacent to the female in
utero [104]. Therefore, there is little reason to believe that
fetal or neonatal ovariectomy would actually render the
female fetus free from estrogens and thus that the sub-
jects in the Jost and Pfeiﬀer studies were not exposed
to any estrogens.
In a second approach to address the role of the ovary
in sexual diﬀerentiation, female rats were ovariectomized
on the day of birth and subsequently re-implanted (or
not) with ovaries until the age of puberty in order to
determine whether ovaries are needed to be present to
develop the potential to show lordosis behavior in adult-
hood. Thus, both Lisk [56] and Gerall et al. [35] reported
that female rats which were ovariectomized on the day of
birth had lower lordosis quotients after adult treatment
with estradiol and progesterone than females which either
kept their ovaries [56] or were ovariectomized at birth and
subsequently implanted with ovaries from the day of birth
until day 60 [35]. In addition, neonatally castrated male
rats implanted with ovaries at several diﬀerent periods
between birth and day 60 showed higher lordosis quo-
tients than neonatally castrated males which were not
given ovarian implants [29,35]. In another study [16],
the possession of ovaries beyond the age of puberty atten-
uated the ability of an injection of testosterone propionate
on postnatal day 4 to reduce later lordotic responses of
female rats to ovarian hormones. Also, subcutaneous
administration of a silastic capsule containing estradiol
over postnatal days 30–40 enhanced their later lordotic
responsiveness in both male and female rats that were
gonadectomized on day one after birth whereas estradioltreatment over postnatal days 10–20 was less eﬀective in
feminizing this capacity [93]. These early behavioral
results thus suggest that exposure to a (low) level of estro-
genic stimulation over a postnatal interval between birth
and the age of puberty facilitates the later capacity to dis-
play female sexual behavior; however, they do not pro-
vide incontrovertible evidence that estradiol normally
contributes to the development of female sexual behavior
in female mammals. First, the eﬀects of neonatal ovariec-
tomy on the potential to show lordosis behavior later in
life were only transient since any diﬀerences in female sex-
ual behavior disappeared following repeated testing [35].
Second, the study by Whalen and Edwards [113] actually
showed no eﬀect of neonatal ovariectomy on later lordo-
sis behavior. Male and female rats which were gonadecto-
mized on the day of birth, showed equivalent levels of
receptivity as gonadally intact female rats. Finally, it
was never experimentally established that these ovarian
implants actually secreted estradiol.
Therefore, in a third approach to investigate the
potential role for estrogens in the development of the
female brain, estrogen action was inhibited pharmacolog-
ically by either treating newborn female rats with the
estrogen receptor antagonist tamoxifen [26] or adminis-
tering the aromatase inhibitor 1,4,6-androstatriene-3,17-
dione (ATD; [12]) to female ferrets during embryonic
development. Dohler et al. [26] showed that neonatal
treatment of female rats with tamoxifen decreased their
later capacity to show lordosis behavior whereas concur-
rent neonatal administration of a low dose of estradiol
benzoate prevented this eﬀect. Likewise, Baum and Tobet
[12] found that female ferrets which were treated prena-
tally with ATD and then treated in adulthood with a
low or moderate dose of estradiol benzoate displayed
decreased acceptance quotients when paired with a stim-
ulus male. However, these later two studies also did not
provide conclusive evidence of a role of estrogen in
female development. First, in addition to its anti-estro-
genic actions, tamoxifen can exert estrogen-like agonist
actions in the brain [61]. Therefore, the observed reduc-
tion in lordosis behavior induced by administering
tamoxifen neonatally to female rats [26] may actually
have resulted from a partial defeminization of the brain
by the estradiol-like actions of tamoxifen on neural estra-
diol receptors. Finally, prenatally ATD-treated female
ferrets and control females displayed equivalent, high,
acceptance quotients when tested after receiving a high
dose of estradiol benzoate in adulthood [12] again indi-
cating that ATD-treated females were capable of display-
ing full-blown receptive behavior.
Thus, there are certainly indications for a role of estro-
gens in the development of the female brain; however, it
has been diﬃcult to provide conclusive evidence for such
a role. As a result, the hypothesis languished since the
mid-1980s due to the absence of a suitable animal model
in which rigorously to assess the possible contribution of
estradiol to the development of the female brain.
Fig. 2. Lordosis quotients of female wild-type (WT), heterozygous (HET),
and aromatase knockout (ArKO) mice. All females were ovariectomized
in adulthood and subsequently treated with estradiol and progesterone
prior to each behavioral test with a sexually active male. *p < 0.05
compare to WT and HET females. Data shown are means (±SEM) of a
total of ﬁve tests.
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development of the female brain
The introduction of the aromatase knockout (ArKO)
mouse [33,44,97], which is deﬁcient in aromatase activity
due to a targeted mutation in the Cyp19 gene, has provided
a new model in which to study the role of estradiol in the
development of the brain and behavior. The ArKO model
provides unique research opportunities in that it allows the
study of animals that are devoid of endogenous estrogen
production but whose genetic deﬁciency can be corrected
at the phenotypic level by simply administering exogenous
estrogens since they have functional estrogen receptors.
This model is therefore more amenable to the experimental
testing of the eﬀects of estrogen on the development of the
brain than the models in which estrogen action was inhib-
ited pharmacologically [12,26] or those in which the estra-
diol receptor has been disrupted (ERKO). In the latter
case, the phenotypic correction is diﬃcult if not impossible.
Thus by administering estradiol to adult ArKO mice, one
can assess the consequences of the absence of estradiol bio-
synthesis and cellular action earlier in life and thus distin-
guish between organizational and activational eﬀects of
estradiol on the brain and behavior. This makes the ArKO
mouse an excellent model to readdress the question
whether the normal female-typical diﬀerentiation of the
brain and behavior requires perinatal exposure to
estrogens.
3.2.1. Reduced female sexual behavior in female ArKO mice
In a ﬁrst experiment, we determined whether lordosis
behavior was aﬀected in female ArKO mice [8]. If the
female brain really develops by default, i.e. in the absence
of any estrogens, lordosis behavior of female ArKO mice
should be indistinguishable of that of normal, wild-type
(WT) female mice. Thus, female mice of three genotypes,
i.e. wild-type (WT), heterozygous (HET), and homozygous
ArKO, were ovariectomized in adulthood and subse-
quently implanted with a silastic capsule containing crys-
talline estradiol (diluted 1:1 with cholesterol). All females
were injected subcutaneously with 500 lg progesterone 2–
4 h before each lordosis test with a sexually active male.
We found that the display of lordosis in response to the
mounts of the stimulus male was severely impaired in
ArKO females (Fig. 2). The same hormone treatment
was, however, eﬀective in inducing lordosis behavior in
WT and HET females. In contrast with previous studies
[12,35], the reduction in lordosis behavior observed in
ArKO females did not disappear with repeated testing or
prolonged (>6 weeks) of estradiol treatment in adulthood
suggesting permanent eﬀects of early estradiol deprivation
on the later potential to show female sexual behavior.
The absence of lordosis behavior in ArKO females could
have been caused by a partial defeminization of their brains
due to the presence of phytoestrogens in the food. In con-
trast with endogenous estrogens, phytoestrogens are gener-
ally non-steroidal in nature and have lower aﬃnities forestrogen-binding plasma proteins such as AFP [69]. They
may thus evade the protective actions of AFP and freely
enter the brain where they could interfere with brain sexual
diﬀerentiation [55,85,114]. This suggests that phytoestro-
gens could be a potential source of estrogen action in the
ArKO female brain, in particularly in the absence of any
local competition with endogenous estrogens for binding
to neural estradiol receptors. Furthermore, Kudwa et al.
[51] showed that ArKO females whose mothers were fed
a phytoestrogen-free diet showed higher lordosis quotients
(equivalent to those of WT females) than ArKO females
whose mothers were fed a phytoestrogen-rich diet suggest-
ing that estrogens present in diet can attenuate the display
of female sexual behavior in ArKO mice. Furthermore,
Kudwa et al. [51] proposed that these phytoestrogens prob-
ably act via the ERb receptor since male ERbKO mice
were capable of showing lordosis behavior in adulthood
following castration and subsequent treatment with estra-
diol and progesterone [51], and phytoestrogens have been
shown to preferentially bind to the ERb receptor [52].
However, it is unlikely that the eﬀects observed in our
ArKO mice [8] relate to an estrogenic action by phytoestro-
gens since (i) our mice were fed a mouse chow (UAR 03,
Epinay sur Orge, France) that does not appear to have
any biologically active estrogens, as revealed by its lack
of eﬀect on uterine growth and on the growth of estro-
gen-dependent cell lines (M. Huard, UAR, personal com-
munication), and (ii) we recently observed very low,
almost non-detectable, progesterone receptor (PR) levels
in the medial preoptic (MPN) and ventromedial nuclei
(VMN) of gonadally intact ArKO mice of both sexes at
several postnatal ages (days 10, 20, 30, and 40; Fig. 4;
unpublished results). The latter animals were derived of
mothers fed the same diet as in our previous study [8].
The results on PR expression provide the best evidence
for the lack of any signiﬁcant estrogenic action in the
ArKO brain during development since previous studies
by Wagner and colleagues [80–82,105,106] have clearly
Fig. 3. Mounting behavior of female wild-type (WT), heterozygous
(HET), and aromatase knockout (ArKO) mice. All females were ovari-
ectomized in adulthood and tested once for mounting behavior with an
estrous female when treated with testosterone and then once more when
treated with both testosterone and estradiol (5 lg/mouse/day). *p < 0.05
compared to WT and HET females, #p < 0.05 compared to WT females.
Data shown are means ± SEM.
J. Bakker, M.J. Baum / Frontiers in Neuroendocrinology 29 (2008) 1–16 5shown that the sex diﬀerence in PR levels in the MPN and
VMN, with fetal and neonatal males showing a higher PR
expression than females, depends on the production of
estradiol acting via the ERa receptor in the developing
male brain. For instance, maternal administration of the
aromatase inhibitor ATD signiﬁcantly decreased hypotha-
lamic PR expression in male rat fetuses [82], whereas 3 days
of administering testosterone propionate or the synthetic
estrogen DES (but not dihydrotestosterone) to pregnant
female rats over embryonic days 19–22 stimulated hypo-
thalamic PR levels in female oﬀspring when they were
killed on E22 [82]. The sex diﬀerence in PR expression in
the MPN, which also exists in mice, is abolished in trans-
genic mice lacking the functional ERa gene [105]. In the
rat, the female-typical proﬁle of PR expression develops
after birth. Thus ovariectomy on postnatal day 4 prevented
the female-typical increase in PR levels observed between
day 10 and 28 in the MPN [80]. Interestingly, preliminary
results from our laboratory also suggest a role for postna-
tal estrogens in the development of PR in the female
mouse. We observed a similar increase in PR levels in
WT female mice between days 10 and 30 after birth,
whereas this increase was completely absent in ArKO
females, conﬁrming the lack of any estrogen action in this
mouse model.
It seems unlikely that the deﬁcit in lordosis behavior can
be attributed to excessive androgen action during develop-
ment leading to a masculinization and defeminization of
the brain in ArKO females. Previous work on another
strain of ArKO mice [33] has indicated that ArKO mice
of both sexes are exposed to increased plasma levels of tes-
tosterone during adulthood. These increased levels of
androgens probably result from the interruption of the ste-
roid feedback on the gonadotropin secretion, which is
known to be mediated by estrogens, as suggested by the
increased levels of circulating luteinizing hormone and fol-
licle-stimulating hormone in these mice. Alternatively, the
increase in plasma testosterone could be caused, at least
in part, by the accumulation of the androgenic substrate,
which can no longer be transformed into an estrogen by
the ovaries because of the disruption of the aromatase
gene. Because the fetal and neonatal ovaries are not very
active [53,108,109], it is unlikely that this increase in andro-
gen levels actually takes place during early development,
but since no data are available to evaluate this question,
it could be speculated that increased levels of androgens
contribute to the development of the behavioral phenotype
of ArKO mice. Thus to determine whether the absence of
lordosis behavior in ArKO females did not result from
masculinization and defeminization of their brains by
excessive androgen action during development, new groups
of female WT, HET, and ArKO mice were tested for their
potential to show male-typical sexual behavior with an
estrous female. Female subjects were ovariectomized and
implanted subcutaneously with a silastic capsule containing
crystalline testosterone. Following several (>3) weeks of
testosterone treatment, female ArKO mice showed nomounting behavior whereas WT and, to a lesser extent,
HET females readily displayed mounting and intromis-
sion-like behaviors (Fig. 3). The addition of estradiol
(5 lg/mouse/day) to the testosterone treatment stimulated
a little mounting and intromission-like behavior in ArKO
females, but not to the levels shown by WT and HET
females (Fig. 3). Such an outcome would not have occurred
had ArKO females been exposed to high levels of testoster-
one perinatally capable of masculinizing their coital capac-
ity. These results also suggest that estrogens organize
mounting behavior in mice to some extent since ArKO
females showed no or very little mounting behavior and
HET females showed intermediate levels of male sexual
behavior, thereby indicating a dose-dependent eﬀect of
estrogens on this behavior. By contrast, results obtained
in male ArKO mice strongly suggest that male sexual
behavior is organized by androgens and not estrogens since
almost normal levels of male sexual behavior could be
induced in male ArKO mice when treated in adulthood
with estrogens in combination with dihydrotestosterone
[9]. In addition, work from the group by Sato et al. [86]
using androgen receptor knockout mice (ARKO), also pro-
vided evidence of the diﬀerentiation of male sex behavior
by androgens. Male ARKO showed very little mounting
behavior, whereas female mice treated with DHT perina-
tally showed high levels of mounting behavior, but this
eﬀect of perinatal DHT treatment was not observed in
female ARKO mice [86]. Finally, to make matters even
more confusing, recent data obtained in mice carrying the
testicular feminization (Tfm) mutation of the androgen
receptor suggest that male sexual behavior is not organized
in the mouse since estrogen-treated male and female mice
including Tfm mice, showed equivalent, high levels of
mounting behavior [17]. Perhaps the sex diﬀerence in
mounting behavior lies in the sensitivity to adult steroid
treatment, i.e. larger doses of testosterone or estradiol are
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to male mice. In the Bodo and Rissman study [17], mice
were tested using adult estradiol treatment by silastic
implant (5 mm of 17b-estradiol diluted 1:1 with choles-
terol). This treatment has been shown to lead to very high
levels of estradiol [110] and has been used to induce lordo-
sis behavior in female mice in our laboratory (e.g.
[8,46,47]). Thus, this treatment did not allow for the detec-
tion of any possible genotype diﬀerences in sensitivity to
estradiol in activating male sexual behavior. Clearly more
studies are needed to determine whether male sexual
behavior is organized or not by steroids in the mouse and
if so, by which steroids. It is possible that in mice, as in fer-
rets [95], fetal exposure to estrogens followed by neonatal
exposure to testosterone is required for complete masculin-
ization of male-typical mating behavior. It should be noted
that even though ArKO male mice readily mounted and
intromitted an estrous female when treated with estrogens
and DHT in adulthood [9], they rarely showed any ejacula-
tory behavior, suggesting a possible contribution of estro-
gens to the organization of male sexual behavior.
Taken together, the results obtained in female ArKO
mice [8] are best explained by assigning an active role for
estradiol in females in the development of female sexual
behavior. At present, these results provide the best avail-
able evidence aﬃrming a role of estradiol in female brain
sexual diﬀerentiation.
3.2.2. Neural mechanisms potentially aﬀected in female
ArKO mice
The reduction in lordosis behavior observed in female
ArKO mice [8] may reﬂect deﬁcits in (i) the neural circuitry
regulating the lordosis reﬂex and/or (ii) the neural mecha-
nisms regulating sexual motivation and sexual partner pref-
erence. Classically, studies of female sexual behavior have
concentrated on the neural and hormonal control of lordo-
sis behavior in the female rat (for a detailed description, see
[73]). Brieﬂy, male mounting stimulates pressure receptors
on the ﬂanks, posterior rump, tail base, and perineum of
the female. Axons of these receptors form a sensory nerve
that projects to the dorsal root of the ganglion of the spinal
cord. Then, the signal is transmitted to the reticular forma-
tion in the brain stem and the midbrain central gray area.
When the female is in estrus, i.e. when estradiol concentra-
tions are high, several brain regions including the ventro-
lateral portion of the VMN (a brain region rich in
estrogen receptors) and the MPN, activate via the midbrain
central gray, medullary reticular formation, and medial
geniculate body, the spinal motoneurons innervating the
back muscles critical to the display of lordosis [23]. Thus,
the VMN plays a critical role in integrating hormonal
and sensory information necessary for the display of lordo-
sis in female rodents. Accordingly, lesions of the VMN, or
destruction of its aﬀerent and eﬀerent ﬁbers, typically
reduce the frequency of lordosis behavior in female rats
[20,60,72] and hamsters [59], whereas implants of estradiol
into the VMN induce lordosis behavior in ovariectomizedfemale rats [84]. Our preliminary results (unpublished) indi-
cated that gonadally intact ArKO females, which were not
supplemented with any estrogens, show much lower levels
of PR in the VMN than WT females. Whether the estradiol
treatment used to induce female sexual receptivity in our
previous study [8] also normalized PR expression in the
VMN of ArKO females has not yet been investigated.
However, preliminary results from Kudwa et al. (Kudwa,
Schank, Honda, and Rissman, SBN abstracts, 2001) sug-
gest that adult treatment with estradiol failed to induce
normal, WT female, levels of PR expression in the VMN
of ArKO females indicating a contribution of postnatal
estradiol to the development of PR receptors, as was
already suggested by the work of Quadros et al. [80]. Fur-
ther studies are needed to determine whether the hor-
monal–neural circuitry of lordosis behavior has not been
feminized in ArKO females and thus whether there is an
active contribution of postnatal estradiol to the develop-
ment of this circuit.
In contrast with the neural and hormonal control of lor-
dosis behavior, very few studies have concentrated on other
aspects of female sexual behavior, including proceptivity
(i.e. sexual motivation) and sexual partner preference. Nev-
ertheless, the ability to seek out and identify potential
mates is as critical to female sexual behavior as is the
capacity to display the lordosis reﬂex when mounted by a
male. Rodent species use primarily odors to identify indi-
viduals of their own species and accordingly, release to
their environment a wide variety of volatile and non-vola-
tile odors via extraorbital lacrimal glands [49], skin glands,
urine, and feces. Two diﬀerent olfactory systems have
evolved to detect these odors. It is generally thought that
the main olfactory system is used to detect a wide variety
of volatile odorants derived from food and potential preda-
tors, among many sources, whereas the accessory olfactory
system evolved to detect and process a subset of non-vola-
tile odors that inﬂuence a variety of reproductive and
aggressive behaviors in mammalian species [32,48]. How-
ever, recent evidence points to an important role for the
main olfactory system in detecting and processing olfactory
cues used for mate recognition [46,47,89]. In female mice,
olfactory cues have been shown to facilitate the display
of lordosis behavior. Peripherally induced anosmia by
intranasal application of zinc sulfate solution attenuated
lordosis behavior in hormone-primed female mice [30,46]
whereas removal of the vomeronasal organ actually com-
pletely abolished lordosis behavior in estrogen and proges-
terone-treated female mice [47] thereby emphasizing the
importance of the accessory olfactory system in the control
of female sexual behavior. Thus the reduction in lordosis
behavior observed in female ArKO mice may reﬂect deﬁcits
in the detection and processing of olfactory cues. For
instance, it is possible that ArKO female mice did not rec-
ognize the stimulus male on the basis of his odors and as a
result did not become sexually receptive. If so, then this
would suggest a role for estrogens in the activation and/
organization of olfactory function. Indeed, sex diﬀerences
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being better able than males to detect male-derived odors.
For instance, sows are signiﬁcantly better than boars at
using decreasing concentrations of the volatile male pig
pheromone, androstenone, as a discriminative stimulus in
operant tests for a sucrose award [28]. These sex diﬀerences
may not only be restricted to the detection of opposite-sex
odors, but may also involve same-sex odors. Using habitu-
ation/dishabituation tests to determine odor attraction
thresholds, female mice responded more reliably than male
mice to low concentrations of volatile urinary odors from
either sex [11]. The greater olfactory sensitivity observed
in female mice probably reﬂects perinatal actions of gona-
dal hormones since these sex diﬀerences were already
observed in long-term gonadectomized mice suggesting
that gonadal hormones are not necessary to activate this
behavior [11]. Furthermore, Dorries et al. [28] showed that
the olfactory performance of neonatally castrated male
pigs falls between those of sows and boars indicating a con-
tribution of perinatal androgens and/or estrogens in the
ability to detect androstenone. Thus, we hypothesized that
olfactory investigation of conspeciﬁc odors is aﬀected in
ArKO females due to them being deprived of estrogens
during perinatal development. Indeed, in our initial study
([8]; Fig. 4) we observed that female ArKO mice displayed
reduced levels of olfactory investigation directed towards
volatile odors emitted from either estrous female or male
conspeciﬁcs when provided with a choice between both
odor sources in a Y-maze [8]. Female subjects were ovari-
ectomized in adulthood and treated over a prolonged (>3
weeks) period of time with estradiol indicating that the
reduction in olfactory investigation could not be corrected
by supplementing ArKO females with estradiol (Fig. 4). By
contrast, no diﬀerences were observed between ArKO and
WT females in olfactory investigation of soiled beddingFig. 4. Total time spent investigating volatile odors by female wild-type
(WT), heterozygous (HET), and aromatase knockout (ArKO) mice when
given the choice between volatile body odors from an intact male versus
those from an estrous female in a Y-maze. All female subjects were
ovariectomized in adulthood and ﬁrst tested for their odor preferences
when receiving testosterone and then when receiving estradiol. *p < 0.05
compared to WT and HET females. Data shown are means ± SEM of two
successive tests.which contains primarily non-volatile odors and are
thought to be detected and processed by the accessory
olfactory system. These results thus suggest in particular,
deﬁcits in main olfactory function in ArKO females. There-
fore, in a follow-up study [76], we determined whether this
reduction in olfactory investigation reﬂect deﬁcits in the
ability of the main olfactory system to detect and/or
discriminate volatile odors derived from male as opposed
to female conspeciﬁcs. Using habituation/dishabituation
tests, we found that gonadectomized ArKO and WT mice,
which were tested without any sex hormone replacement,
reliably distinguished between undiluted volatile urinary
odors of either adult males or estrous females versus
deionized water as well as between these two urinary odors
themselves (Fig. 5). Thus, the previously observed deﬁcits
[8] in the preference of female ArKO mice to approach
volatile body odors from conspeciﬁcs of either sex cannot
be attributed to an inability of ArKO mice to detect or
discriminate volatile urinary odors from males versus
females.
Next, we compared the ability of ArKO and WT mice to
detect decreasing concentrations of either male or female
urinary odors [76]. We found a clear-cut sex diﬀerence in
urinary odor attraction thresholds among WT mice: WT
females responded to higher urine dilutions than male
mice, thereby conﬁrming previous results obtained by
Baum and Keverne [11]. Interestingly, male ArKO mice
resembled WT females in their ability to detect lower con-
centrations of urinary odors, raising the possibility that the
observed sex diﬀerence among WT mice in urine attraction
thresholds results from the perinatal actions of estrogen in
the male nervous system. Female ArKO mice failed to
respond to some of the female urine dilutions, suggesting
olfactory-perceptual deﬁcits. Therefore, the ability of
ArKO and WT mice to discriminate low concentrationsFig. 5. Time spent by ovariectomized female wild-type (WT), heterozy-
gous (HET), and aromatase knockout (ArKO) mice investigating deion-
ized water or volatile urinary stimuli. *p < 0.05 between the time spent
investigating the third presentation of a particular stimulus and the ﬁrst
presentation of the subsequent stimulus.
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food-motivated operant (olfactometer) task [112]. All mice
were gonadectomized in adulthood and subsequently trea-
ted with a low (1 lg) dose of estradiol benzoate. All groups
of animals, regardless the sex or the genotype, eventually
learned to distinguish between intact male urine and
estrous female urine. Among the four groups of subjects,
WT females performed the worst and ArKO females the
best in discriminating several pairs of urinary and non-bio-
logical (amyl versus butyl acetate) odors. This was most
apparent when animals had to discriminate volatile urinary
odors from ovariectomized female mice treated with estra-
diol sequenced with progesterone versus estradiol alone
(Fig. 6): ArKO females quickly learned this discrimination
whereas WT females and males as well as ArKO males
failed to do so. Thus these results suggest that the weak
performance of ArKO females in the habituation/dishabit-
uation tests of odor detection [76] cannot be attributed to
deﬁcits in the function of the main olfactory system per
se. It is possible that the previously observed [8] decrease
in olfactory investigation of volatile body odors in Y-maze
tests actually reﬂected an increased olfactory sensitivity in
ArKO females, i.e. less proximal investigation of the source
of urinary odors was needed for ArKO females to distin-
guish the diﬀerent odors presented in the two arms of the
Y-maze. The superior olfactory performance of ArKO
females over WT females may have resulted from an
increased estradiol-induced olfactory neurogenesis in these
females.
Taken together, the deﬁcits observed in lordosis behav-
ior of female ArKO mice [8] are not due to deﬁcits in their
capacity to recognize the stimulus male on the basis of hisFig. 6. Ability of wild-type (WT) and aromatase knockout (ArKO) male
and female mice to learn to discriminate between two female urine stimuli
in an olfactometer test. S+ = rewarded stimulus; S = non-rewarded
stimulus. Data expressed as means ± SEM. *p < 0.05 compared to WT
males and females, and ArKO males.odors. There are certainly indices of a reduced motivation
in ArKO females to investigate conspeciﬁc odors [8,76], but
when appropriately motivated (by food-depriving them for
instance), they are capable and even better than WT
females in discriminating between diﬀerent pairs of biolog-
ical and non-biological odors [112]. Thus, the neural sys-
tems underlying the reduced display of lordosis behavior
in ArKO females do most likely not include the olfactory
systems.
4. Role of a-fetoprotein in the sexual diﬀerentiation of the
rodent brain
The role of a-fetoprotein (AFP) in brain sexual diﬀeren-
tiation has been another topic of debate in the ﬁeld of
behavioral neuroendocrinology during the 1970–1980s
[26,64,99]. AFP was discovered about half a century ago
to be the major serum fetal protein in mammals [1,15].
AFP is produced in great quantities during fetal life by
the endodermal cells of the visceral yolk sac, by the hepa-
tocytes, and in lesser amounts, by the gastrointestinal tract
[3,90,94]. The protein produced by the embryo is trans-
ferred into the maternal blood circulation, and levels of
AFP in the maternal serum are commonly used as a diag-
nostic marker to reveal developmental anomalies of the
fetus [19,42,70]. Abnormally high levels of AFP in the
maternal serum indicate an elevated risk of neural tube
defects of the fetus such as spina biﬁda or anencephaly
[54], whereas abnormally low levels indicates an elevated
risk of Down’s syndrome [22]. The synthesis of AFP
decreases rapidly after birth and only trace amounts are
detected in adults [3,83].
Until recently, the physiological function of AFP during
embryonic development remained largely unidentiﬁed. The
observation that AFP is able to bind estrogens with high
aﬃnity in rats and mice has led to the suggestion that
AFP may play a role in the sexual diﬀerentiation of the
brain, in particularly in protecting the female brain from
excessive exposure to estrogens that are circulating in high
concentrations during the critical period of sexual diﬀeren-
tiation ([64,83]; Fig. 7a). However, in addition to binding
estradiol, AFP, like albumin, is able to bind other steroids
as well as endogenous and exogenous substances such as
fatty acids, bilirubin, and various pharmaceutical agents,
suggesting that AFP may play a transportation role in gen-
eral (for review see [37]). In fact, an intracellular pool of
AFP of unknown function has been detected in the brain
cytosol during fetal life in various vertebrate species,
including rats, mice, sheep, pig, and humans (reviewed in
[99]). AFP is present within neurons of both sexes at all
stages of development of the central nervous system from
the postmitotic neuroblast to more diﬀerentiated neurons.
However AFP is not present in the adult mouse brain
underlying that AFP may have important functions within
the developing central nervous system. Furthermore,
although some reports exist of local synthesis (e.g. [2,57],
there is no convincing evidence that intraneuronal AFP is
Fig. 7. Two competing hypotheses on the role of a-fetoprotein (AFP), a fetal plasma protein that binds estrogens with high aﬃnity, in female sexual
diﬀerentiation: (a) AFP may serve to keep estrogens from entering the brain (hypothesis proposed by [64]) and (b) AFP may deliver estrogens to speciﬁc
brain regions to promote feminization of the neural mechanisms controlling female sexual behavior (hypothesis proposed by [99]).
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be detected in the fetal, newborn, or adult mouse brain [88]
suggesting that the observed high levels of AFP immunore-
activity in the brain must be derived from external sources,
perhaps by receptor-mediated endocytosis [99,100]. These
latter observations suggest that AFP may have more than
the attributed ‘‘protective’’ role [64] and may serve as a
transport carrier for estrogens into the brain [99];
Fig. 7b). In particular, the discrete intracytoplasmic locali-
zation of rodent AFP suggests its possible active involve-
ment in estrogen-sensitive neurons during the critical
period of sexual diﬀerentiation. Since there is a diﬀerence
of several orders of magnitude between the aﬃnity con-
stants for estradiol binding by AFP (KD 10
8 M; [87])
and by the estrogen receptor (KD 10
11 M) the subsequent
intracytoplasmic dissocation of the AFP/estradiol complex
in estrogen-receptor containing neurons could liberate the
steroid and lead directly to receptor binding. By doing
so, intraneuronal AFP could thus provide target neurons
of both sexes with low levels of estrogen and thus serve
as an intracellular reservoir of estrogen (Fig. 7b). It should
be noted, however, that although a widespread intraneuro-
nal localization of immunoreactive AFP is observed in
numerous brain regions in rodents of both sexes, estro-
gen-receptor containing regions of the brain, such as the
diagonal band of broca, the medial preoptic area, the arcu-
ate, and the ventral premammillary nuclei of the hypothal-
amus, and the medial and cortical amygdaloid nuclei are
characterized by a complete absence of AFP-immunoreac-
tivity [98]. This latter observation clearly questions the pos-sible role of AFP as transporter of estrogens to estrogen-
sensitive neural targets during the sexual diﬀerentiation of
the brain. While the estrogen-binding capacity of the
rodent AFP emphasizes its potential importance for brain
sexual diﬀerentiation, its possible role with respect to its
capacity to bind substances other than estrogens, such as
teratogens and polyunsaturated free fatty acids such as ara-
chidonic, docosahexaenoic, and docosatetraenoic acides, of
which their importance has been shown with regard to neu-
ral development in mammals, including humans [21,77],
should not be overlooked, in particularly since these
ligands are bound to AFP in all species [103]. Taken
together, clearly opposing views exist on the function of
AFP during development and in particularly during sexual
diﬀerentiation of the brain (Fig. 7). These diﬀerent hypoth-
eses have not been experimentally tested due to the absence
of a suitable animal model. Some indirect evidence for a
protective role of AFP comes from a study [62] showing
that the addition of neonatal serum to [3H] estradiol
strongly reduced its uptake into the brain of adult female
rats. Furthermore, the study by Mizejewski and Vonnegut
[67] in which neonatal male and female mice were injected
intracranially with anti-AFP immunoglobulin, showed an
androgenization of the female mouse, suggesting a protec-
tive role of AFP. However, these mice also had gross neu-
rological lesions, i.e. external hydrocephaly, as a result of
the intracranial injection with anti-AFP thereby making
it diﬃcult to interpret the data.
The recent introduction of an AFP-KO mouse [34] has
now made it possible to test these opposing hypotheses
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diﬀerentiation.
4.1. The a-fetoprotein knockout mouse
4.1.1. a-Fetoprotein knockout mice are infertile
Afp knockout mice were generated by replacing an Afp
genomic fragment extending from exon 1 to intron 3
(AFP-KO1), or extending from exon 2 to intron 3 (AFP-
KO2), by a IRES-LacZ-neo selection cassette [34]. The
AFP-KO1 allele was generated in two diﬀerent genetic
backgrounds, the outbred CD-1 and the inbred C57Bl/6j
strain, whereas the AFP-KO2 allele was generated in only
the CD-1 background. Both invalidations gave rise to via-
ble homozygous animals. AFP-KO animals are apparently
normal with males being fertile, but females are not, owing
to a complete absence of ovulation [34]. AFP-KO ovaries
contain follicles at diﬀerent stages of maturation, including
the last Graﬁaan follicle stage, but no corpora lutea, indic-
ative of ovulation, could be detected, which is in accor-
dance with the low levels of progesterone in the serum.
Reciprocal ovarian transplantation experiments demon-
strated that AFP-KO ovaries are functional: AFP-KO ova-
ries transplanted in normal mice were able to ovulate and
the transplanted females generated pups from the mutated
parental oocytes. By contrast, WT ovaries implanted into
female AFP-KO mice did not show any ovulation. How-
ever, ovulation in AFP-KO females could be induced by
injecting gonadotropins indicating that their ovaries are
responsive to any signals from the hypothalamus–pituitary.
These results thus suggest that the infertility observed in
AFP-KO females is not due to any defects in the ovaries,
but is most likely caused by a deﬁcit in hypothalamic–pitu-
itary–gonadal (HPG) axis. Indeed, microarray studies [24]
showed that several genes implicated in female fertility,
such as Egr1, Cish2, Ptprf, Psa, and Tkt, were down-regu-
lated in the pituitary of AFP-KO females. Furthermore,
several genes implicated in the GnRH pathway, such as
the GnRH receptor gene, and several genes activated by
the GnRH receptor (cFos, Egr2, Tgfb li4, and Ptp4a1)
are down-regulated in female AFP-KO mice [24]. In the
hypothalamus, the gene encoding the hypothalamic GnRH
decapeptide is itself down-regulated, suggesting a dysfunc-
tion of the GnRH pathway in AFP-KO females.
4.1.2. Brain and behavior of AFP knockout mice are
defeminized
In order to determine whether their infertility reﬂected
anomalies in the sexual diﬀerentiation of the brain, we ﬁrst
tested female AFP-KO mice for their ability to show lordo-
sis behavior when paired with a sexually active male [6].
Groups of female WT, HET, and AFP-KO mice were
ovariectomized in adulthood and subsequently implanted
with a silastic capsule containing crystalline estradiol
(diluted 1:1 with cholesterol). All female subjects received
500 lg of progesterone subcutaneously 2–4 h before test-
ing. AFP-KO females never showed any lordosis behaviorin any of the three behavioral tests, whereas WT and HET
females showed substantial levels of lordosis behavior
(Fig. 8a). Very similar results were obtained in all AFP-
KO mouse models generated [6]. These results suggest that
AFP-KO females have lost their ability to show lordosis
behavior. As discussed previously, olfaction plays a pivotal
role in the expression of lordosis behavior in female mice
[30,46,47]. The complete absence of lordosis behavior in
female AFP-KO mice may be explained by a reduced moti-
vation to investigate male-derived odors. Therefore we
investigated odor preferences in AFP-KO mice of the two
diﬀerent background strains [7]. AFP-KO females always
preferred to investigate male over female odors when given
the choice between these two odor stimuli in a Y-maze, and
thus remained very female-like in this regard. The absence
of lordosis behavior in these females can thus not be
explained by a reduced motivation of AFP-KO females
to investigate male-derived odors.
We also determined whether AFP-KO females have an
increased capacity to display male-typical sexual behaviors.
Normal female mice can show substantial levels of mount-
ing and intromission-like behaviors when ovariectomized
in adulthood and treated with high doses of either testos-
terone or estradiol [8,111] suggesting that this behavior is
less sexually diﬀerentiated than the ability to show lordosis
behavior. Nevertheless, mount frequencies were higher in
AFP-KO females compared to WT females and this eﬀect
was already visible in HET females ([6]; Fig. 8b). The latter
have probably been exposed to increased concentrations of
estrogens due to having decreased levels of AFP [34]. The
binding aﬃnity of estradiol for AFP is lower than for its
own receptor stressing the importance of having excess lev-
els of AFP during fetal development [5]. These results also
point to a role of fetal estrogens in the organization of male
sexual behavior in the mouse and thus further support the
notion of a possible synergistic role of estradiol and andro-
gen receptor activation in masculinization of mating
behavior capacity ([9,86,95]; see discussion in previous
section).
4.1.3. Reduced female sexual behavior in female ArKO mice
This behavioral phenotype in AFP-KO females was
associated with neurochemical changes [6]. The sexually
dimorphic expression of tyrosine hydroxylase (TH) and
vasopressin (VP) were used as indices of brain sexual diﬀer-
entiation. The number of TH-expressing neurons in the
anteroventral preoptic area (AVPv) is sexually dimorphic
with females having greater numbers than males
[91,92,96]. The AVPv plays a critical role in female repro-
ductive function by transducing hormonal feedback con-
trolling hypothalamic GnRH release and consequent
pituitary luteinizing hormone secretion, as well as that it
is needed for hormonally induced ovulation [115]. By con-
trast, males show a denser expression of VP particularly in
the lateral septum than females [25]. We conﬁrmed the sex
diﬀerences in the number TH-expressing neurons in the
AVPV as well as in VP expression in the lateral septum.
Fig. 8. Behavioral and neurochemical phenotype of female a-fetoprotein
knockout (AFP-KO)mice. (a) Lordosis quotients of femalewild-type (WT),
heterozygous (HET), and AFP-KO mice. All female subjects were ovari-
ectomized in adulthood and subsequently tested with estradiol and
progesterone prior to each behavioral test. *p < 0.05 compared to WT and
HET females. (b) Mounting behavior of female WT, HET, and AFP-KO
females when paired with an estrous female. Female subjects were
ovariectomized in adulthood and subsequently treated with estradiol.
*p < 0.05 compared to WT females. (c) Numbers of tyrosine hydroxylase-
immunoreactive (TH-IR) neurons in the anteroventral preoptic area
(AVPv). Female subjects were ovariectomized in adulthood and treated
with estradiol. *p < 0.05 compared to WT males, and HET and AFP-KO
females, #p < 0.05 compared to WT males and females and AFP-KO
females. (d) Brain vasopressin expression assessed by the fractional areas
covered by vasopressin-IR structures in the posterior lateral septum.Female
subjects were ovariectomized in adulthood and treated with estradiol.
*p < 0.05 compared to all female groups.
J. Bakker, M.J. Baum / Frontiers in Neuroendocrinology 29 (2008) 1–16 11Female AFP-KO mice had decreased, male-like numbers
of tyrosine hydroxylase (TH) neurons in the anteroventral
preoptic area (AVPV; Fig. 8c) which may be related to
their infertility [24,34]. By contrast, female AFP-KO mice
showed female-typical densities of VP-immunoreactive
ﬁbers in the lateral septum (Fig. 8d). The latter result was
rather surprising in light of earlier observations showing
an important role for perinatal estrogens in the sexual dif-
ferentiation of the vasopressin system in the rat [43]. It is
possible, however, that the development of sex diﬀerences
in the vasopressin system relies more on the perinatal
action of androgens than on that of estrogens in the mouse,
an idea supported by recent ﬁndings in male ArKO mice
([79]; unpublished results). Furthermore, sex chromosomes
may also contribute directly to the development of the sex-
ually dimorphic vasopressin system in mice [25]. Indeed,
XY males and XY female mice (i.e. females with a deletion
of the Sry gene) are more masculine than XX mice with
regard to the density of vasopressin-expressing ﬁbers in
the lateral septum [25]. So perhaps there is an interaction
between estrogens and sex chromosomes in the sexual dif-
ferentiation of this neuropeptide system.
4.1.4. AFP protects the developing female brain from
estrogens
Our observations of a complete absence of female sexual
behavior and male-like numbers of TH neurons in the
AVPV in female AFP-KO mice did not allow us to discrim-
inate between the two opposing theories about the role of
AFP in brain sexual diﬀerentiation (Fig. 7). Both hypothe-
ses would predict that male AFP-KO mice would be more
or less normal but that the females would be aﬀected. It
could be argued that the brains of AFP-KO females were
defeminized because they were no longer protected from
the estrogens produced by their mother or male siblings.
This argument would support the hypothesis that AFP
serves primarily to protect the female brain from excessive
exposure to estrogens [64]. By contrast, it could also be
argued that the brains of AFP-KO females were not femi-
nized because they were lacking the AFP to transport small
quantities of estrogens to target brain areas and thus to
promote the diﬀerentiation of these structures in a female
direction. This argument would favor the hypothesis that
AFP is needed to transport estrogens into the brain and
thus has an active role in female sexual diﬀerentiation [99].
To discriminate between these competing hypotheses,
we blocked estrogen production during prenatal develop-
ment by treating pregnant female mice heterozygous for
the Afp mutation with the aromatase inhibitor ATD [6].
If AFP protects the female brain from being exposed to
estrogens, AFP-KO oﬀspring of ATD-treated mothers
should not be defeminized, as the ATD treatment would
prevent the formation, during prenatal development, of
high defeminizing levels of estradiol. However, if AFP
actually acts as an estrogen carrier and is thus necessary
for the feminizing the female brain, then the AFP-KO oﬀ-
spring of ATD-treated mothers should not show normal
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estrogens (absence of the steroid and its carrier).
Prenatal treatment with ATD completely rescued lordo-
sis behavior in AFP-KO females (Fig. 9a). Furthermore,
such ATD-treated AFP-KO females had female-like num-
bers of TH neurons in the AVPv (Fig. 9b). Accordingly, the
fertility of AFP-KO females was also restored as well as
gene expression in the HPG [24]. These results clearly dem-
onstrate that AFP serves to protect the female brain from
becoming masculinized and defeminized by estrogens cir-
culating during embryonic development [6].
These ﬁndings do not explain, however, why AFP is
found inside neurons without being locally produced [88].
Little or no intraneuronal AFP is found in limbic, hypotha-
lamic, and amygdaloid areas, whereas large amounts are
present in adjacent regions [98]. This could indicate that
AFP protects from estrogens those brain regions involved
in reproductive function, such as the hypothalamus, butFig. 9. Female phenotype of AFP-KO females is rescued by prenatal
treatment with the aromatase inhibitor ATD. (a) Lordosis quotients of
wild-type (WT), AFP-KO, and heterozygous (HET-ATD) and AFP-KO
females treated prenatally with ATD (AFP-KO-ATD). All female subjects
were ovariectomized in adulthood and treated subsequently with estradiol
and progesterone. *p < 0.05 compared to WT, HET-ATD, and AFP-KO-
ATD females. (b) Numbers of tyrosine hydroxylase-immunoreactive (TH-
IR) neurons in the anteroventral preoptic region (AVPv). Female subjects
were ovariectomized in adulthood and treated with estradiol. *p < 0.05
compared to WT males and AFP-KO females.may deliver estrogens to other brain regions, and thereby
may inﬂuence the sexual diﬀerentiation of various func-
tions, including non-reproductive behaviors such as learn-
ing and memory capacity [63]. However, it should be
noted that the mechanisms controlling the diﬀerentiation
of sex diﬀerences in learning and memory capacity remain
to be elucidated. Perhaps a closer look at the neurons that
contain AFP will suggest a function for this protein in these
cells. In addition, it will be interesting to determine whether
non-reproductive behaviors have been altered in AFP-KO
mice and if so, whether this can be corrected or not by
blocking estrogen synthesis during fetal development.
Whether AFP plays a similar protective role in the sex-
ual diﬀerentiation of the human brain is unclear. There are
diverging views in the literature as to whether human AFP
has any estrogen-binding capacities. Nunez et al. [71]
reported a low-binding aﬃnity of human serum for steroid
hormones during embryonic and early postnatal develop-
ment. By contrast, both Uriel et al. [101] and Arnon
et al. [4] showed that human AFP could actually bind
estrogens. In either case, human AFP-derived peptides
are able to display some anti-estrogenic activity
[14,66,102]. These AFP-derived peptides are currently
under investigation as potential agents for treating estro-
gen-dependent breast cancers and other tumors [13,66].
Finally, it is not known if a protection from maternal estro-
gens is actually required since the reigning idea is that in
humans, androgens, not estrogens, are the primary cause
of brain masculinization (reviewed in [107]). Furthermore,
primates do not undergo receptive defeminization, i.e.
males will accept repeated mounting by other males by dis-
playing the posture normally associated with female recep-
tivity. As a result, primates may not need a protective role
of AFP against a defeminizing action of fetal estradiol
exposure [10].
5. Conclusions and future directions
The results obtained in AFP-KO mice show that the
principal action of prenatal estrogen exposure, regardless
of whether it occurs in female or male mice, is to defeminize
and, to some extent, masculinize brain and behavior. Fur-
thermore, AFP, which binds estradiol circulating in the
female fetus with aﬃnity and capacity, protects the devel-
oping brain from a male-typical organization by this ste-
roid. So at ﬁrst glance, these ﬁndings are at odds with
the results [8] obtained in female ArKO mice implying an
active contribution of estrogens to the development of
the female brain. However, such a dual role of estradiol
in brain sexual diﬀerentiation was earlier suggested by
Dohler et al. [26]. Based on their results, they proposed
the ‘‘progressive hypothesis of brain sexual diﬀerentiation’’
which asserts that (i) the embryonic brain is not diﬀerenti-
ated in either males or females, and (ii) under the inﬂuence
of moderate levels of estrogen, female-typical neural and
behavioral traits develop whereas under the inﬂuence of
high levels of estrogen, male-typical neural and behavioral
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estrogen action is blocked by AFP in the developing
female, thus if estrogens normally contributes to the devel-
opment of the female brain, they most likely act postnatally
when the amount of AFP has decreased substantially and
AFP no longer plays a protective role. AFP levels are the
highest at birth, after which they decrease by about 50%
during the ﬁrst 24 h. Only trace levels (about 0.01% of fetal
levels) are detected at 3 weeks of age in rats [83]. Thus pre-
sumably when the ovaries start to secrete estrogens at day 7
after birth [53], AFP no longer plays a signiﬁcant role.
Consistent with a postnatal role of estradiol in feminization
of the brain is the observation by Steward and Cygan [93]
of an enhanced of female receptivity in neonatally gonadec-
tomized male and female rats treated with estradiol over
postnatal days 30–40. We propose thus that the defeminiz-
ing action of estradiol normally occurs prenatally in males
and is avoided in fetal females because of the protective
actions of AFP. We further propose that the feminizing
action of estradiol normally occurs in genetic females
between birth and the age of puberty (postnatal days 40–
50). Accordingly, several studies in which estrogen expo-
sure was manipulated in both sexes during the perinatal
developmental period have suggested that diﬀerent critical
periods exit for male- and female-typical organization of
the brain [80,82]. Thus, prenatal exposure to estrogens
induces the male-typical pattern of PR expression in the
MPN and VMN, whereas postnatal exposure to estrogens
leads to the female pattern of PR expression in these brain
regions. Future studies should take advantage of the ArKO
mouse model to determine the contribution of postnatal
estradiol to the development of female sexual behavior. If
normal levels of lordosis behavior can be induced in female
ArKO mice by treating them with estradiol postnatally,
then these results would provide the best evidence for a
normal role of postnatal estradiol in promoting female-typ-
ical brain and behavioral sexual diﬀerentiation.
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